Financials
- Market Capitalization 1.59 B
- Employee 140
- Founded 2011
- CEO N/A
- Website www.absci.com
- Headquarter Washington, United States
- FIGI BBG011N54CJ8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.15
ratio cours/chiffre d'affaires
170.48
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2130 | VIR Vir Biotechnology, Inc. - Common Stock | 9.72 USD | -2.41% | -4.33% | +11.34% | +62.54% | 1.64 B USD | ||
| 2131 | INVA Innoviva, Inc. - Common Stock | 22.21 USD | -0.13% | +0.45% | -2.24% | +24.64% | 1.64 B USD | ||
| 2156 | GHRS GH Research PLC - Ordinary Shares | 25.35 USD | -4.38% | -3.17% | +19.74% | +79.03% | 1.57 B USD | ||
| 2159 | AVBP ArriVent BioPharma, Inc. - Common Stock | 33.64 USD | -0.15% | -3.03% | +9.51% | +53.40% | 1.57 B USD |